EDWARD REYNOLDS: Open Payments
NPI 1013942549 · SUMTER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,898 in 122 payments from 19 companies in 2025. Trend: 2023 $2,580 · 2024 $2,922 · 2025 $2,898
Food & beverage: $2,543Education: $355
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 26 | $538 |
| ABBVIE INC. | 17 | $374 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $359 |
| Amgen Inc. | 12 | $269 |
| Regeneron Healthcare Solutions, Inc. | 11 | $265 |
| Arcutis Biotherapeutics, Inc. | 3 | $225 |
| UCB, Inc. | 8 | $175 |
| Galderma Laboratories, L.P. | 10 | $140 |
| Incyte Corporation | 5 | $132 |
| Lilly USA, LLC | 5 | $108 |
Products named: TREMFYA, DUPIXENT, OTEZLA, SKYRIZI, Zoryve, ILUMYA, Bimzelx, NEMLUVIO.
Industry payments across SC — which companies pay providers there.
